Search

HEALIUS LTD

Cerrado

SectorSalud

0.79 -2.47

Resumen

Variación precio

24h

Actual

Mínimo

0.78

Máximo

0.79

Métricas clave

By Trading Economics

Ingresos

-13M

Ventas

-14M

682M

Margen de beneficio

-1.933

Empleados

3,699

EBITDA

-101M

75M

Recomendaciones

By TipRanks

Recomendaciones

Vender

Estimación a 12 meses

-0.55% downside

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-2.2M

542M

Apertura anterior

3.26

Cierre anterior

0.79

Noticias sobre sentimiento de mercado

By Acuity

14%

86%

15 / 371 Clasificación en Healthcare

HEALIUS LTD Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

17 oct 2025, 18:13 UTC

Principales Movimientos del Mercado

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17 oct 2025, 17:05 UTC

Principales Movimientos del Mercado

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

17 oct 2025, 15:03 UTC

Principales Movimientos del Mercado

Obook Shares Sink Following Public Debut

17 oct 2025, 14:41 UTC

Principales Movimientos del Mercado

Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug

17 oct 2025, 23:25 UTC

Adquisiciones, fusiones, absorciones

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 oct 2025, 22:15 UTC

Charlas de Mercado

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 oct 2025, 21:15 UTC

Charlas de Mercado

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17 oct 2025, 21:07 UTC

Charlas de Mercado

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17 oct 2025, 21:07 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

17 oct 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

17 oct 2025, 20:34 UTC

Charlas de Mercado

Deere Is Reaching the End of Its Downcycle -- Market Talk

17 oct 2025, 20:27 UTC

Charlas de Mercado

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17 oct 2025, 19:46 UTC

Charlas de Mercado

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17 oct 2025, 19:45 UTC

Charlas de Mercado

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17 oct 2025, 18:45 UTC

Charlas de Mercado

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17 oct 2025, 17:51 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 oct 2025, 17:51 UTC

Charlas de Mercado

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17 oct 2025, 17:44 UTC

Charlas de Mercado

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17 oct 2025, 17:35 UTC

Charlas de Mercado

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17 oct 2025, 16:20 UTC

Charlas de Mercado
Ganancias

Tech, Media & Telecom Roundup: Market Talk

17 oct 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

17 oct 2025, 16:14 UTC

Charlas de Mercado

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17 oct 2025, 16:04 UTC

Charlas de Mercado

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17 oct 2025, 15:58 UTC

Charlas de Mercado

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17 oct 2025, 15:56 UTC

Ganancias

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17 oct 2025, 15:43 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

17 oct 2025, 15:43 UTC

Charlas de Mercado

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

17 oct 2025, 14:58 UTC

Charlas de Mercado

Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk

17 oct 2025, 14:41 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 oct 2025, 14:35 UTC

Charlas de Mercado
Ganancias

American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk

HEALIUS LTD Esperado

Precio Objetivo

By TipRanks

-0.55% caída

Estimación a 12 meses

Media 0.796 AUD  -0.55%

Máximo 1 AUD

Mínimo 0.62 AUD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para HEALIUS LTD Dist en los últimos 3 meses.

Consenso

By TipRanks

Vender

10 ratings

0

Comprar

7

Mantener

3

Vender

Sentimiento

By Acuity

15 / 371 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de HEALIUS LTD

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics, QML Pathology, TML Pathology, Abbott Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories, medical centers, patient collection centers, and community imaging centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
help-icon Live chat